Eurofins CDMO – helping you advance your programs with speed and confidence

Published: 19-Feb-2021

Eurofins CDMO, India facility, provides NCE/API development and manufacturing services for complex and niche small molecule programs from preclinical to Phase III and commercial supply

Eurofins understands your need for the right balance of speed and cost with the highest quality and endeavour to develop a partnership that creates mutual success.

The facilities are well equipped and the team has expertise and experience to develop new, safe and efficient synthetic route for complex molecules. Eurofins provide seamless transition from candidate selection to commercialisation. The company offers regulatory-compliant analytical services to support Chemistry and Manufacturing Controls (CMC) requirements.

To support your drug substance requirements, Eurofins services include:

  • Scouting of new, innovative and scalable synthetic routes  
  • Process development and process safety assessment 
  • Fit for Purposes optimisation
  • Polymorph screening & salt selection 
  • Analytical method development and validation
  • Impurity Identification, Isolation and Characterisation  
  • cGMP manufacturing
  • CMC support for IND filing
  • Stability studies as per ICH

You may also like